Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas
about
Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in ChordomaAnalysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomasThe role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.Molecular characterization of putative chordoma cell linesSystemic therapy options for unresectable and metastatic chordomas.Recurrent chromosomal copy number alterations in sporadic chordomas.Frequent activation of EGFR in advanced chordomas.Novel therapeutic targets in chordoma.Converging paths to progress for skull base chordoma: Review of current therapy and future molecular targets.Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin.Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors.Generation of a patient-derived chordoma xenograft and characterization of the phosphoproteome in a recurrent chordoma.A zebrafish model of chordoma initiated by notochord-driven expression of HRASV12Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis.Novel targeted therapies in chordoma: an update.Multidisciplinary approach of lumbo-sacral chordoma: From oncological treatment to reconstructive surgery.EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.Akt blocks the tumor suppressor activity of LKB1 by promoting phosphorylation-dependent nuclear retention through 14-3-3 proteins.The notochord: structure and functions.
P2860
Q30278895-88BED0FD-FDEE-427A-B969-972CAB61C26EQ33273701-30511975-70EC-4B91-B9B7-277BF7036840Q33274011-3ED0F615-399B-4BCE-8677-27E40B3CCDF6Q33274040-00AA781C-6EEF-4D81-9B5C-84597A32750AQ33274146-BD9A865D-F883-4352-8EDD-44C7E5C0467AQ33274149-2043C998-28A1-4E4D-89B4-3FCDA1A1C33FQ33274473-1D8FFC76-95D9-4E46-A83C-4F0A55AA2F4DQ33274528-EFE88788-5FB9-484C-B567-F85FD08EDA56Q33274821-CCE875D5-9532-43E2-BBF9-8C36AD8D5DB1Q33274834-5CD5AE17-BABA-4A01-B82F-2F3CDB257D01Q33274913-758E9359-0436-49CB-BA59-7FD37935AD45Q33275031-AF82212E-AB83-4BF7-83EB-C316E8D292ABQ33275053-568EA881-F7D4-4F58-AA81-7C111D6CA379Q33275157-787A4EA9-6F43-4D85-8278-BC3CE9B90B5DQ33275653-49E6F08F-2A36-4E22-9D8C-077B1ACB6F24Q33275786-59653E5D-D53F-4000-8943-D7FC24C58DBDQ33276007-5C5527C9-9F8A-45C4-896F-FE5DE5D8CC3AQ33276506-6F5C4D63-3D1C-49FC-8AAE-4CA4A3809FC4Q35964171-62C43DB5-528D-4C64-BF23-FEEAE30FBD79Q38400611-2BFA4E4D-4E5F-4C17-96A0-F4BB122D8DCA
P2860
Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@ast
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@en
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@nl
type
label
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@ast
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@en
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@nl
prefLabel
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@ast
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@en
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@nl
P2093
P2860
P3181
P1476
Aberrant hyperactivation of ak ...... ignaling in sporadic chordomas
@en
P2093
Carolyn Polizzano
Gunnlaugur P Nielsen
Sangyeul Han
Vijaya Ramesh
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-08-2364
P407
P577
2009-03-15T00:00:00Z